Prof. Dr. Irfan Cicin

Prof. Dr. Irfan Cicin
Academic Title :
Prof. Dr.

Prof. Dr. Irfan Cicin is a Medical Oncology specialist at Medical Park Florya.

Education and Academic Qualifications

  • Bachelor of Medicine, Faculty of Medicine - İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, 1991-1997
  • Internal Medicine Specialization, Faculty of Medicine - Trakya Üniversitesi Tıp Fakültesi, 1997-2002
  • Medical Oncology Specialization, Faculty of Medicine - Trakya Üniversitesi Tıp Fakültesi, 2002-2004
  • Associate Professor, Faculty of Medicine - Trakya Üniversitesi Tıp Fakültesi, 2010-2015
  • Professor, Faculty of Medicine - Trakya Üniversitesi Tıp Fakültesi, 2015
  • Air Force Etimesgut Military Hospital (2004-2005)
  • Faculty of Medicine - Trakya Üniversitesi (Medical Oncology) (2005-2008)
  • Elazığ Training and Research Hospital (2008-2010)
  • Medical Park Florya (Present)
  • Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH study. Bilici A, Olmez OF, Kaplan MA, Oksuzoglu B, Sezer A, Karadurmus N, Cubukcu E, Sendur MAN, Aksoy S, Erdem D, Basaran G, Cakar B, Shbair ATM, Arslan C, Sumbul AT, Sezgin Goksu S, Karadag I, Cicin I, Gumus M, Selcukbiricik F, Harputluoglu H, Demirci U. Acta Oncol. 2023 Apr 21:1-10. doi: 10.1080/0284186X.2023.2202330.
  • Major and minor salivary gland cancers: A multicenter retrospective study. Hacioglu MB, Erdogan B, Bardakcı M, Algın E, Gulbagcı B, Hacibekiroglu I, Hamdard J, Olmez OF, Akkus H, Oksuzoglu B, Goksu SS, Dae SA, Sumbul AT, Ugraklı M, Karaagac M, Sahin E, Cabuk D, Ozer O, Yavuzsen T, Arıkan R, Köstek O, Atcı MM, Sakin A, Deligonul A, Bayır D, Dincer M, Unsal O, Yazıcı O, Zeynelgil E, Gulmez A, Harputluoglu H, Erol C, Sendur MAN, Aytekin A, Akagunduz B, Oner I, Er O, Oztosun B, Gumus M, Biricik FS, Aykan MB, Karadurmus N, Degerli E, Demirci NS, Turkmen E, Şakalar T, Secmeler S, Tanrıverdi O, Alkan A, Kemal Y, Cil I, Unal C, Iriagaç Y, Alan O, Balli S, Urun Y, Ozcan E, Turhal NS, Cicin I. Head Neck. 2023 Apr 21. doi: 10.1002/hed.27376. Online ahead of print.
  • Cancer-related hypercalcemia and potential treatments Elvina Almuradova1 and Irfan Cicin2 Frontiers in Endocrinology. 22 March 2023, DOI 10.3389/fendo.2023.1039490.
  • Efficacy and safety results by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2-, node-positive, high-risk early breast cancer. Paluch-Shimon S, Neven P, Huober J, Cicin I, Goetz MP, Shimizu C, Huang CS, Lueck HJ, Beith J, Tokunaga E, Contreras JR, de Sant'Ana RO, Wei R, Shahir A, Nabinger SC, Forrester T, Johnston SRD, Harbeck N. Ther Adv Med Oncol. 2023 Feb 3;15:17588359231151840. doi: 10.1177/17588359231151840. eCollection 2023.
  • Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy. Karacin C, Oksuzoglu B, Demirci A, Keskinkılıç M, Baytemür NK, Yılmaz F, Selvi O, Erdem D, Avşar E, Paksoy N, Demir N, Göksu SS, Türker S, Bayram E, Çelebi A, Yılmaz H, Kuzu ÖF, Kahraman S, Gökmen İ, Sakin A, Alkan A, Nayır E, Uğraklı M, Acar Ö, Ertürk İ, Demir H, Aslan F, Sönmez Ö, Korkmaz T, Celayir ÖM, Karadağ İ, Kayıkçıoğlu E, Şakalar T, Öktem İN, Eren T, Urul E, Mocan EE, Kalkan Z, Yıldırım N, Ergün Y, Akagündüz B, Karakaya S, Kut E, Teker F, Demirel BÇ, Karaboyun K, Almuradova E, Ünal OÜ, Oyman A, Işık D, Okutur K, Öztosun B, Gülbağcı BB, Kalender ME, Şahin E, Seyyar M, Özdemir Ö, Selçukbiricik F, Kanıtez M, Dede İ, Gümüş M, Gökmen E, Yaren A, Menekşe S, Ebinç S, Aksoy S, İmamoğlu Gİ, Altınbaş M, Çetin B, Uluç BO, Er Ö, Karadurmuş N, Erdoğan AP, Artaç M, Tanrıverdi Ö, Çiçin İ, Şendur MAN, Oktay E, Bayoğlu İV, Paydaş S, Aydıner A, Salim DK, Geredeli Ç, Yavuzşen T, Doğan M, Hacıbekiroğlu İ. BMC Cancer. 2023 Feb 10;23(1):136. doi: 10.1186/s12885-023-10609-8.
Share :